The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia

被引:123
作者
Klemm, Lars [1 ,2 ,3 ]
Duy, Cihangir [1 ,2 ,3 ]
Iacobucci, Ilaria [4 ]
Kuchen, Stefan [5 ]
von Levetzow, Gregor [1 ,2 ,3 ]
Feldhahn, Niklas [3 ]
Henke, Nadine [3 ]
Li, Zhiyu [5 ]
Hoffmann, Thomas K. [3 ,8 ]
Kim, Yong-mi [1 ,2 ]
Hofmann, Wolf-Karsten [6 ]
Jumaa, Hassan [7 ]
Groffen, John [1 ,2 ]
Heisterkamp, Nora [1 ,2 ]
Martinelli, Giovanni [4 ]
Lieber, Michael R. [1 ]
Casellas, Rafael [5 ]
Mueschen, Markus [1 ,2 ,3 ]
机构
[1] Univ So Calif, Leukemia & Lymphoma Program, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90027 USA
[2] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA
[3] Univ Dusseldorf, D-40225 Dusseldorf, Germany
[4] Univ Bologna, Dept Hematol & Oncol L & A Seragnoli, I-40138 Bologna, Italy
[5] NIAMSD, NIH, Bethesda, MD 20892 USA
[6] Univ Heidelberg Hosp, Dept Hematol Oncol, D-68167 Mannheim, Germany
[7] Max Planck Inst Immunobiol, Freiburg, Germany
[8] Univ Duisburg Essen, Dept Otorhinolaryngol, D-45147 Essen, Germany
关键词
INDUCED CYTIDINE DEAMINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; KINASE DOMAIN MUTATIONS; ACTIVATION-INDUCED DEAMINASE; CLASS SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; TYROSINE KINASE; DNA DEAMINATION; CHRONIC PHASE; C-MYC;
D O I
10.1016/j.ccr.2009.07.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chronic myeloid leukemia (CIVIL) is induced by BCR-ABL1 and can be effectively treated for many years with Imatinib until leukemia cells acquire drug resistance through BCR-ABL1 mutations and progress into fatal B lymphoid blast crisis (LBC). Despite its clinical significance, the mechanism of progression into LBC is unknown. Here, we show that LBC but not CIVIL cells express the B cell-specific mutator enzyme AID. We demonstrate that AID expression in CIVIL cells promotes overall genetic instability by hypermutation of tumor suppressor and DNA repair genes. Importantly, our data uncover a causative role of AID activity in the acquisition of BCR-ABL1 mutations leading to Imatinib resistance, thus providing a rationale for the rapid development of drug resistance and blast crisis progression.
引用
收藏
页码:232 / 245
页数:14
相关论文
共 50 条
[31]   Current outlook on drug resistance in chronic myeloid leukemia (CML) and potential therapeutic options [J].
Sundaram, Daniel Nisakar Meenakshi ;
Jiang, Xiaoyan ;
Brandwein, Joseph M. ;
Valencia-Serna, Juliana ;
Remant, K. C. ;
Uludag, Hasan .
DRUG DISCOVERY TODAY, 2019, 24 (07) :1355-1369
[32]   Concomitant L248V With E225V Mutation in the BCR-ABL Gene Associated With Rapid Chronic Myeloid Leukemia Lymphoid Blast Crisis [J].
Tungjitviboonkun, Songphol ;
Wachirapornpruet, Pawitthorn ;
Unsuwan, Sorrawit .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
[33]   Possible implication of IKAROS gene deletion and BCR-ABL1 variants in progression of chronic myeloid leukemia to lymphoid blast crisis in childhood: a single-institution experience [J].
Moschovi, Maria ;
Adamaki, Maria ;
Athanasiadou, Anastasia ;
Divane, Aspasia ;
Karytianou, Anna ;
Tourkantoni, Natalia .
LEUKEMIA & LYMPHOMA, 2015, 56 (08) :2460-2462
[34]   ZFX Facilitates Cell Proliferation and Imatinib Resistance in Chronic Myeloid Leukemia Cells [J].
Wu, Jingjing ;
Wei, Bin ;
Wang, Qian ;
Ding, Yihan ;
Deng, Zhikui ;
Lu, Xueying ;
Li, Yufeng .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2016, 74 (02) :277-283
[35]   Chronic Myeloid Leukemia in a Patient with Hepatitis B Virus Infection: A Case Report [J].
Hailan, Yousef Mohammed Ali ;
Mudawi, Deena ;
Yassin, Mohamed A. .
CASE REPORTS IN ONCOLOGY, 2021, 14 (02) :1004-1009
[36]   Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs) [J].
Imeri, Jusuf ;
Desterke, Christophe ;
Marcoux, Paul ;
Telliam, Gladys ;
Sanekli, Safa ;
Barreau, Sylvain ;
Erbilgin, Yucel ;
Latsis, Theodoros ;
Hugues, Patricia ;
Sorel, Nathalie ;
Cayssials, Emilie ;
Chomel, Jean-Claude ;
Bennaceur-Griscelli, Annelise ;
Turhan, Ali G. .
CELLS, 2023, 12 (04)
[37]   Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis [J].
Bin Salman, Ahmed A. ;
Zaidi, Abdul Rehman Zia ;
Altaf, Syed Yasir ;
AlShehry, Nawal F. ;
Tailor, Imran K. ;
Motabi, Ibraheem H. ;
Zaidi, Syed Ziauddin A. .
AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 :1-9
[38]   Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph plus lymphoid blast crisis of chronic myeloid leukaemia [J].
Breccia, Massimo ;
Serrao, Alessandra ;
Salaroli, Adriano ;
Loglisci, Giuseppina ;
Zacheo, Irene ;
Alimena, Giuliana .
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (05) :612-613
[39]   KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3+ blast phase chronic myeloid leukemia [J].
Kwon, Hyun-Jin ;
Shin, Ji Eun ;
Khan, Amir ;
Park, So Yeon ;
Kim, Jiyoung ;
Lee, Jee-Young ;
Lee, Doohyun ;
Lee, Seungyeon ;
Im, Chun Young ;
Moon, Heegyum ;
Han, Ye Ri ;
Tamai, Minori ;
Akahane, Koshi ;
Inukai, Takeshi ;
Lee, Wonhwa ;
Kim, Hyelim ;
Kim, Hong Nam ;
Ahn, Sung-Min ;
Park, Hyun Woo ;
Kim, Dong-Wook .
MOLECULAR CANCER, 2025, 24 (01)
[40]   B cell chronic lymphocytic leukemia: Lessons learned from studies of the B cell antigen receptor [J].
Chiorazzi, N ;
Ferrarini, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :841-894